ADAGE: Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over
Study Details
Study Description
Brief Summary
Colorectal cancer occurs mainly in elderly patients. Recent estimation showed that in France more than 50% of the patients diagnosed with a colorectal cancer are 70 years old or more. Adjuvant chemotherapy has demonstrated a benefit on disease-free survival and overall survival after a stage III colon cancer resection. Nevertheless adjuvant chemotherapy is poorly used in elderly patients. Prognostic improvement with chemotherapy based on 5FU is suggested by a post-hoc analysis of randomized prospective clinical trial. But elderly patients in this study were highly selected and patients older than 80 represented only 0.7% of the total population. Thus, there is still a concern about the benefit of adjuvant 5FU-based chemotherapy in very elderly unselected patients.
The recommended treatment for stage III adjuvant chemotherapy is a combination of fuoropyrimidine and oxaliplatin. Nevertheless oxaliplatin did not demonstrated survival advantage in elderly patients.
Altogether there are still two matters of debate:
-
First, is there a benefit of fluoropyrimidine-based adjuvant chemotherapy for unfit elderly patients?
-
Second, is there a benefit of oxaliplatin-based adjuvant chemotherapy for fit elderly patients? The aim of this randomized phase III study is to evaluate the benefit for disease-free survival of adjuvant chemotherapy in elderly patient and which chemotherapy.
The elderly patient population will be dichotomized into two groups according to physician's choice after a multidisciplinary evaluation involving a geriatrician, with two different randomization assignments. The patients with an expected life-expectancy below 4 years according Lee score are excluded of this study.
Some biological tumour abnormalities are more frequently observed in elderly (i.e. mismatch repair deficiency), therefore an evaluation of specific biological prognostic factors is needed in elderly population.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Detailed Description
Colorectal cancer occurs mainly in elderly patients. Recent estimation showed that in France more than 50% of the patients diagnosed with a colorectal cancer are 70 years old or more. Adjuvant chemotherapy has demonstrated a benefit on disease-free survival and overall survival after a stage III colon cancer resection. Nevertheless adjuvant chemotherapy is poorly used in elderly patients. Prognostic improvement with chemotherapy based on 5FU is suggested by a post-hoc analysis of randomized prospective clinical trial. But elderly patients in this study were highly selected and patients older than 80 represented only 0.7% of the total population. Thus, there is still a concern about the benefit of adjuvant 5FU-based chemotherapy in very elderly unselected patients.
The recommended treatment for stage III adjuvant chemotherapy is a combination of fuoropyrimidine and oxaliplatin. Nevertheless oxaliplatin did not demonstrated survival advantage in elderly patients.
Altogether there are still two matters of debate:
-
First, is there a benefit of fluoropyrimidine-based adjuvant chemotherapy for unfit elderly patients?
-
Second, is there a benefit of oxaliplatin-based adjuvant chemotherapy for fit elderly patients? The aim of this randomized phase III study is to evaluate the benefit for disease-free survival of adjuvant chemotherapy in elderly patient and which chemotherapy.
The elderly patient population will be dichotomized into two groups according to physician's choice after a multidisciplinary evaluation involving a geriatrician, with two different randomization assignments. The patients with an expected life-expectancy below 4 years according Lee score are excluded of this study.
Some biological tumour abnormalities are more frequently observed in elderly (i.e. mismatch repair deficiency), therefore an evaluation of specific biological prognostic factors is needed in elderly population.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: GROUP1 -ARM A LV5FU2 or capecitabine |
Drug: LV5FU2 or capectitabine
|
Experimental: GROUP1-ARMB FOLFOX4 or XELOX |
Drug: FOLFOX4 or XELOX
|
Experimental: GROUP2- ARM C Observation |
Other: Observation
|
Experimental: GROUP2-ARM D LV5FU2 or capecitabine |
Drug: LV5FU2 or capecitabine
|
Outcome Measures
Primary Outcome Measures
- The 3-year disease-free survival [3 years after last patient in]
Secondary Outcome Measures
- Overal survival [5 years after last patient in]
- Observed toxicities, graded according to NCI-CTC v4 [3 years after last patient in]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age ≥ 70 years
-
Patient considered able to receive chemotherapy
-
Lee score detailed faxed to CRGA
-
Stage III colon adenocarcinoma
-
R0 resection of the primary tumor
-
Start of the potential adjuvant chemotherapy within 12 weeks after surgery
-
No prior chemotherapy for colon cancer
-
Geriatric Self-administered questionnaire completed faxed to CRGA
-
Geriatric Questionnaire completed by the team faxed to CRGA
-
Effective contraception for men patients throughout treatment and for at least 6 months after discontinuation of oxaliplatin
-
Consent signed
Exclusion Criteria:
-
Other progressive disease (cancer uncontrolled for less than 2 years)
-
Rectal Cancer (located less than 15 cm from the anal verge endoscopy or sub-peritoneal)
-
ANC <2000 / mm3 for group 1 and ANC <1500 / mm3 for group 2 and platelets <100,000 / mm3 or hemoglobin <9 g / dL
-
Neuropathy for patients in group 1
-
Known deficit of dihydropyrimidine dehydrogenase (DPD)
-
Patients with severe hepatic insufficiency
-
Any contrindication to the drugs used in the study
-
Inability to submit to medical follow-up for geographical, social or psychological reasons.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | CHU de Fort de France | Fort De France | Guadeloupe | France | 97261 |
2 | CH d'Abbeville | Abbeville CEDEX | France | 80142 | |
3 | CROMG | Agen | France | ||
4 | Centre hospitalier du Pays d'Aix | Aix-en-Provence | France | 13616 | |
5 | Centre hospitalier d'Albi | Albi | France | 81000 | |
6 | Clinique Claude Bernard | Albi | France | 81030 | |
7 | Clinique Claude Bernard | Albi | France | ||
8 | Centre Oncogard | Alès | France | 30103 | |
9 | Hôpital Sud | Amiens CEDEX 1 | France | 80054 | |
10 | ICO Site Paul Papin | Angers CEDEX 2 | France | 49055 | |
11 | CHU d'Angers | Angers CEDEX 9 | France | 49933 | |
12 | HOP Privé | Annemasse | France | ||
13 | CH Victor Dupouy | Argenteuil | France | 95107 | |
14 | Hôpital Les Bonnettes | Arras CEDEX | France | 62012 | |
15 | Hôpital Privé Bonnettes | Arras | France | ||
16 | Centre Hospitalier Ardèche Méridionale | Aubenas CEDEX | France | 07205 | |
17 | CH D'Auxerre | Auxerre | France | 89000 | |
18 | Institut Sainte Catherine | Avignon CEDEX | France | 84918 | |
19 | Hôpital Henri Duffaut | Avignon | France | 84902 | |
20 | Hôpital de Bayeux | Bayeux CEDEX | France | 14401 | |
21 | CH Côte Basque | Bayonne CEDEX | France | 64109 | |
22 | Centre d'Oncologie et de Radiothérapie du Pays-Basque | Bayonne | France | 64100 | |
23 | CH de Beauvais | Beauvais | France | 60021 | |
24 | CH de Blois | Blois | France | 41000 | |
25 | CHU Avicenne | BOBIGNY cedex | France | 93009 | |
26 | Polyclinique Bordeaux Nord | Bordeaux CEDEX | France | 33077 | |
27 | Hôpital Duchenne | Boulogne-sur-Mer | France | 62321 | |
28 | Hôpital Pierre Oudot | Bourgoin-Jallieu | France | 38300 | |
29 | Clinique Pasteur Saint Esprit | Brest | France | 29200 | |
30 | CH de Béziers | Béziers | France | 34525 | |
31 | CHU Côte de Nacre | Caen | France | 14033 | |
32 | CH | Cahors | France | ||
33 | Infirmerie Protestante de Lyon | Caluire-et-Cuire | France | 69300 | |
34 | CH William Morey | Chalon-sur-Saône | France | 71100 | |
35 | Hôpital Privé Sainte Marie | Chalon-sur-Saône | France | 71100 | |
36 | Centre Hospitalier Métropole Savoie | Chambery CEDEX | France | 73011 | |
37 | Centre Hospitalier Public du Cotentin | Cherbourg | France | 50102 | |
38 | CH | Cherbourg | France | ||
39 | Centre Hospitalier Général | Châlons-en-Champagne | France | 51005 | |
40 | CHU Estaing | Clermont-Ferrand | France | 63003 | |
41 | Hopitaux Civils de Colmar | Colmar | France | 68024 | |
42 | Centre Hospitalier | Compiègne CEDEX | France | 60321 | |
43 | CH | Contamine sur Arve | France | ||
44 | Centre Hospitalier Sud Francilien | Corbeil-Essonnes | France | 91106 | |
45 | Clinique des Cèdres | Cornebarrieu | France | 31700 | |
46 | Clinique des Cèdres | Cornebarrieu | France | ||
47 | Centre Hospitalier de Dax | Dax CEDEX | France | 40107 | |
48 | Service de médecine | Digne-les-Bains | France | 04000 | |
49 | Hôpital François Mitterand | Dijon CEDEX | France | 21079 | |
50 | Institut de Cancérologie de Bourgogne - GRRECC | Dijon | France | 21000 | |
51 | Centre Goerges François Leclerc | Dijon | France | 21079 | |
52 | CHI Elbeuf-Louviers-Val de Reuil | Elbeuf | France | 76503 | |
53 | CH | Flers | France | ||
54 | CHI de Fréjus Saint-Raphaël | Fréjus | France | 83600 | |
55 | Centre médical des Forcilles | Férolles-Attilly | France | 77150 | |
56 | Centre Hospitalier | Gap | France | 05007 | |
57 | Centre Hospitalier | Gonesse | France | 95500 | |
58 | CH | Gonesse | France | ||
59 | CHU de Grenoble - Hôpital A. Michallon | Grenoble CEDEX | France | 38043 | |
60 | CH Marne La Vallée-Jossigny | Jossigny | France | 77600 | |
61 | CHD Vendée | La Roche-sur-Yon | France | 85925 | |
62 | Groupe Hospitalier de la Rochelle Ré-Aunis | La Rochelle | France | 17019 | |
63 | CH | Le Coudray | France | ||
64 | CH du Mans | Le Mans CEDEX 9 | France | 72037 | |
65 | Centre Oscar Lambret | Lille | France | 59037 | |
66 | CHRU Hôpital Claude Huriez 4eme EST | Lille | France | 59037 | |
67 | Clinique François Chénieux | Limoges | France | 87000 | |
68 | CHU Dupuytren | Limoges | France | 87042 | |
69 | CH | Longjumeau | France | 91164 | |
70 | CHBS - Hôpital du Scorff | Lorient CEDEX | France | 56322 | |
71 | Clinique de la Sauvegarde | Lyon CEDEX 09 | France | 69009 | |
72 | Clinique Mutualiste Eugène André | Lyon | France | 69003 | |
73 | Hôpital Privé Jean Mermoz | Lyon | France | 69008 | |
74 | CHU de Lyon - Croix Rousse | Lyon | France | 69317 | |
75 | CH ST Joseph-ST Luc | Lyon | France | 69365 | |
76 | Hôpital Edouard Herriot | Lyon | France | 69437 | |
77 | Centre Radiologie | Macon | France | ||
78 | Hôpital Européen Marseille | Marseille CEDEX 03 | France | 13331 | |
79 | Hopital Nord | Marseille CEDEX 20 | France | 13915 | |
80 | CHU La Timone | Marseille CEDEX 5 | France | 13385 | |
81 | CH de Meaux | Meaux | France | 77100 | |
82 | Hôpital Layne | Mont-de-Marsan | France | 40024 | |
83 | Hôpital Monod | Montivilliers | France | 76290 | |
84 | Centre Hospitalier | Montélimar | France | 26216 | |
85 | Centre Hospitalier | Morlaix CEDEX | France | 29672 | |
86 | Centre Azuréen de Cancérologie | Mougins | France | 06250 | |
87 | Hôpital Privé du Confluent SAS | Nantes | France | 44277 | |
88 | Hôpital Américain de Paris | Neuilly-sur-Seine | France | 92200 | |
89 | Hôpital Pierre Bérégovoy | Nevers CEDEX | France | 58033 | |
90 | Centre Antoine Lacassagne | Nice CEDEX 2 | France | 06189 | |
91 | Centre Oncogard | Nîmes CEDEX 9 | France | 30029 | |
92 | CHU Carémeau | Nîmes | France | 30029 | |
93 | Hôpital de la Source | Orléans CEDEX 2 | France | 45067 | |
94 | Hôpital Privé des Peupliers | Paris | France | 75013 | |
95 | Hôpital Saint Antoine | Paris | France | 75571 | |
96 | HEGP | Paris | France | ||
97 | Hôpital Cochin | Paris | France | ||
98 | Hôpital Saint Louis | Paris | France | ||
99 | Institut Montsouris | Paris | France | ||
100 | Pitié Salpêtière | Paris | France | ||
101 | Centre Hospitalier | Pau CEDEX | France | 64046 | |
102 | Hôpital Haut Leveque | Pessac CEDEX | France | 33604 | |
103 | CHU Lyon Sud | Pierre-Bénite | France | 64495 | |
104 | Centre CARIO - HCPA | Plérin | France | 22190 | |
105 | Hôpital de la Milétrie | Poitiers | France | 86021 | |
106 | CH Annecy Genevois | Pringy | France | 74374 | |
107 | Polyclinique Francheville | Périgueux | France | 24004 | |
108 | CHU Robert Debré | Reims CEDEX | France | 51092 | |
109 | CHU de Pontchaillou | Rennes CEDEX 9 | France | 35033 | |
110 | Centre Eugène Marquis | Rennes CEDEX | France | 35042 | |
111 | CH | Rodez | France | ||
112 | Hôpital Drome Nord | Romans-sur-Isère | France | 26100 | |
113 | CHU Charles Nicolle | Rouen CEDEX 01 | France | 76031 | |
114 | Clinique Mathilde | Rouen CEDEX | France | 76175 | |
115 | Hôpital Privé Saint Grégoire | Saint Gregoire | France | 35768 | |
116 | ICO - Site René Gauducheau | Saint Herblain | France | 44805 | |
117 | Institut de Cancérologie Lucien Neuwirth | Saint Priest en Jarez | France | 42271 | |
118 | CH | Saint Quentin | France | ||
119 | Institut Curie | Saint-Cloud | France | 92210 | |
120 | Polyclinique Côte Basque Sud | Saint-Jean-de-Luz | France | 64500 | |
121 | Centre Hospitalier de Saint-Malo | Saint-Malo | France | 35403 | |
122 | Hôpital d'Instruction des Armées Begin | Saint-Mandé | France | 94163 | |
123 | Polyclinique Saint Claude | Saint-Quentin | France | 02100 | |
124 | CH Saintonge | Saintes | France | 17108 | |
125 | CH Morlevat | Semur-en-Auxois | France | 21140 | |
126 | CH | Senlis CEDEX | France | 60309 | |
127 | Centre Hospitalier | Sens CEDEX | France | 89108 | |
128 | CH Région Saint Omer | St Omer | France | 62505 | |
129 | Clinique Sainte Anne | Strasbourg | France | 67000 | |
130 | Centre Paul Strauss | Strasbourg | France | 67065 | |
131 | Hôpitaux du Leman | Thonon-les-Bains | France | 74203 | |
132 | Hôpital Sainte Musse | Toulon | France | 83000 | |
133 | Hôpital Sainte Musse | Toulon | France | 83000 | |
134 | Clinique Saint Jean du Languedoc | Toulouse | France | 31077 | |
135 | Hôpitaux Trousseau | Tours CEDEX 9 | France | 37044 | |
136 | Centre Hospitalier | Valenciennes | France | 59322 | |
137 | CHU de Nancy-Bradois | Vandoeuvre les nancy | France | 54511 | |
138 | Institut de Cancérologie de Lorraine | Vandoeuvre les nancy | France | 54519 | |
139 | Paul Brousse | Villejuif | France | ||
140 | Centre Hospitalier | Villeneuve-Saint-Georges | France | 94195 |
Sponsors and Collaborators
- Federation Francophone de Cancerologie Digestive
Investigators
- Principal Investigator: Thomas Aparicio, Pr, FFCD member
Study Documents (Full-Text)
None provided.More Information
Publications
- PRODIGE34-ADAGE